Belc CO., LTD. (TYO:9974)

Verve Therapeutics Revenue

Belc CO., LTD. had revenue of 103.71B JPY in the quarter ending May 31, 2025, with 10.97% growth. This brings the company's revenue in the last twelve months to 398.03B, up 9.83% year-over-year. In the fiscal year ending February 28, 2025, Belc CO., LTD. had annual revenue of 387.78B with 10.21% growth.

• Revenue (ttm): 398.03B
• Revenue Growth: +9.83%
• P/S Ratio: 0.40
• Revenue / Employee: 144.63M
• Employees: 2,752
• Market Cap: 157.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Feb 28, 2025	387.78B	35.92B	10.21%
Feb 29, 2024	351.86B	41.03B	13.20%
Feb 28, 2023	310.83B	10.56B	3.52%
Feb 28, 2022	300.27B	15.81B	5.56%
Feb 28, 2021	284.46B	44.96B	18.77%